A positive move: proton therapy in Australia

A positive move: proton therapy in Australia Australasian Physical & Engineering Sciences in Medicine (2018) 41:1–2 https://doi.org/10.1007/s13246-018-0621-3 GUEST EDITORIAL 1,2 Scott Penfold Published online: 29 January 2018 © Australasian College of Physical Scientists and Engineers in Medicine 2018 In the September 2012 issue of this journal, Juergen Meyer or VMAT) with passively scattered proton therapy (PSPT). in his Guest Editorial “Proton therapy: decisions, decisions” The degree of conformity made possible with newer proton considered the broad and challenging question of whether pencil beam scanning (PBS) exceeds that of PSPT systems proton therapy could be considered a wise investment for in many cases and as such comparisons of IMRT/VMAT and cancer treatment [5]. Discussions concerning this topic usu- PSPT may be unrelated to a comparison of IMRT/VMAT ally centre around the large capital expenditure required and and PBS. The next major advancement may mean a similar the lack of clinical evidence in the form of phase III ran- redundancy in comparing IMRT/VMAT and PBS. So what domized clinical trials (RCTs) supporting proton therapy. are the alternatives? Some suggest that in silico clinical tri- Meyer does not pass any firm judgements concerning the als may be used to determine which technology of the day is cost-benefit of proton therapy. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Australasian Physical & Engineering Sciences in Medicine Springer Journals

A positive move: proton therapy in Australia

Loading next page...
 
/lp/springer_journal/a-positive-move-proton-therapy-in-australia-T8DHqU0SMP
Publisher
Springer Netherlands
Copyright
Copyright © 2018 by Australasian College of Physical Scientists and Engineers in Medicine
Subject
Biomedicine; Biomedicine, general; Biological and Medical Physics, Biophysics; Medical and Radiation Physics; Biomedical Engineering
ISSN
0158-9938
eISSN
1879-5447
D.O.I.
10.1007/s13246-018-0621-3
Publisher site
See Article on Publisher Site

Abstract

Australasian Physical & Engineering Sciences in Medicine (2018) 41:1–2 https://doi.org/10.1007/s13246-018-0621-3 GUEST EDITORIAL 1,2 Scott Penfold Published online: 29 January 2018 © Australasian College of Physical Scientists and Engineers in Medicine 2018 In the September 2012 issue of this journal, Juergen Meyer or VMAT) with passively scattered proton therapy (PSPT). in his Guest Editorial “Proton therapy: decisions, decisions” The degree of conformity made possible with newer proton considered the broad and challenging question of whether pencil beam scanning (PBS) exceeds that of PSPT systems proton therapy could be considered a wise investment for in many cases and as such comparisons of IMRT/VMAT and cancer treatment [5]. Discussions concerning this topic usu- PSPT may be unrelated to a comparison of IMRT/VMAT ally centre around the large capital expenditure required and and PBS. The next major advancement may mean a similar the lack of clinical evidence in the form of phase III ran- redundancy in comparing IMRT/VMAT and PBS. So what domized clinical trials (RCTs) supporting proton therapy. are the alternatives? Some suggest that in silico clinical tri- Meyer does not pass any firm judgements concerning the als may be used to determine which technology of the day is cost-benefit of proton therapy.

Journal

Australasian Physical & Engineering Sciences in MedicineSpringer Journals

Published: Jan 29, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off